A prospective, randomized clinical trial was conducted to evaluate the efficacy of endocrine chemotherapy with uracil and tegafur (in a molar ratio of 4:1 [UFT]) in patients with prostate cancer. The study included two
Manabu Kuriyama, MD, PhD
Advertisement
Articles by Manabu Kuriyama, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
From Conference to Practice: Top 5 Takeaways From EHA 2026
2
Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma
3
Evaluating Bladder-Sparing Strategies and Key GU Data From ASCO 2026
4
Revolutionizing Oncology in the Digital Age: Effects on Health Care Providers
5